Global Biologic Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Biologic Therapeutics market size was valued at US$ 432730 million in 2023. With growing demand in downstream market, the Biologic Therapeutics is forecast to a readjusted size of US$ 842720 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Biologic Therapeutics market. Biologic Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologic Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologic Therapeutics market.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biologic Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologic Therapeutics market. It may include historical data, market segmentation by Type (e.g., Vaccines, Blood Products), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologic Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologic Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologic Therapeutics industry. This include advancements in Biologic Therapeutics technology, Biologic Therapeutics new entrants, Biologic Therapeutics new investment, and other innovations that are shaping the future of Biologic Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologic Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Biologic Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologic Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologic Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologic Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologic Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologic Therapeutics market.
Market Segmentation:
Biologic Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Biologic Therapeutics market size was valued at US$ 432730 million in 2023. With growing demand in downstream market, the Biologic Therapeutics is forecast to a readjusted size of US$ 842720 million by 2030 with a CAGR of 10.0% during review period.
The research report highlights the growth potential of the global Biologic Therapeutics market. Biologic Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biologic Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biologic Therapeutics market.
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Biologic Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biologic Therapeutics market. It may include historical data, market segmentation by Type (e.g., Vaccines, Blood Products), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biologic Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biologic Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biologic Therapeutics industry. This include advancements in Biologic Therapeutics technology, Biologic Therapeutics new entrants, Biologic Therapeutics new investment, and other innovations that are shaping the future of Biologic Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biologic Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Biologic Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biologic Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biologic Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biologic Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biologic Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biologic Therapeutics market.
Market Segmentation:
Biologic Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Vaccines
- Blood Products
- Allergenic Extracts
- Human Cells and Tissues
- Gene Therapies
- Protein
- Cellular Therapies
- Xenotransplantation Products
- Rheumatoid Arthritis
- Anemia
- Cancer
- Diabetes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis Global
- AstraZeneca
- Merck
- GlaxoSmithKline
- Aurobindo Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Therapeutics Market Size 2019-2030
2.1.2 Biologic Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologic Therapeutics Segment by Type
2.2.1 Vaccines
2.2.2 Blood Products
2.2.3 Allergenic Extracts
2.2.4 Human Cells and Tissues
2.2.5 Gene Therapies
2.2.6 Protein
2.2.7 Cellular Therapies
2.2.8 Xenotransplantation Products
2.3 Biologic Therapeutics Market Size by Type
2.3.1 Biologic Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologic Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Biologic Therapeutics Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Anemia
2.4.3 Cancer
2.4.4 Diabetes
2.4.5 Others
2.5 Biologic Therapeutics Market Size by Application
2.5.1 Biologic Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologic Therapeutics Market Size Market Share by Application (2019-2024)
3 BIOLOGIC THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Biologic Therapeutics Market Size Market Share by Players
3.1.1 Global Biologic Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Biologic Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGIC THERAPEUTICS BY REGIONS
4.1 Biologic Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Biologic Therapeutics Market Size Growth (2019-2024)
4.3 APAC Biologic Therapeutics Market Size Growth (2019-2024)
4.4 Europe Biologic Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologic Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologic Therapeutics Market Size by Country (2019-2024)
5.2 Americas Biologic Therapeutics Market Size by Type (2019-2024)
5.3 Americas Biologic Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Therapeutics Market Size by Region (2019-2024)
6.2 APAC Biologic Therapeutics Market Size by Type (2019-2024)
6.3 APAC Biologic Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologic Therapeutics by Country (2019-2024)
7.2 Europe Biologic Therapeutics Market Size by Type (2019-2024)
7.3 Europe Biologic Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Biologic Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologic Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGIC THERAPEUTICS MARKET FORECAST
10.1 Global Biologic Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Biologic Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Biologic Therapeutics Forecast
10.1.3 APAC Biologic Therapeutics Forecast
10.1.4 Europe Biologic Therapeutics Forecast
10.1.5 Middle East & Africa Biologic Therapeutics Forecast
10.2 Americas Biologic Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Biologic Therapeutics Market Forecast
10.2.2 Canada Biologic Therapeutics Market Forecast
10.2.3 Mexico Biologic Therapeutics Market Forecast
10.2.4 Brazil Biologic Therapeutics Market Forecast
10.3 APAC Biologic Therapeutics Forecast by Region (2025-2030)
10.3.1 China Biologic Therapeutics Market Forecast
10.3.2 Japan Biologic Therapeutics Market Forecast
10.3.3 Korea Biologic Therapeutics Market Forecast
10.3.4 Southeast Asia Biologic Therapeutics Market Forecast
10.3.5 India Biologic Therapeutics Market Forecast
10.3.6 Australia Biologic Therapeutics Market Forecast
10.4 Europe Biologic Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Biologic Therapeutics Market Forecast
10.4.2 France Biologic Therapeutics Market Forecast
10.4.3 UK Biologic Therapeutics Market Forecast
10.4.4 Italy Biologic Therapeutics Market Forecast
10.4.5 Russia Biologic Therapeutics Market Forecast
10.5 Middle East & Africa Biologic Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Biologic Therapeutics Market Forecast
10.5.2 South Africa Biologic Therapeutics Market Forecast
10.5.3 Israel Biologic Therapeutics Market Forecast
10.5.4 Turkey Biologic Therapeutics Market Forecast
10.5.5 GCC Countries Biologic Therapeutics Market Forecast
10.6 Global Biologic Therapeutics Forecast by Type (2025-2030)
10.7 Global Biologic Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Biologic Therapeutics Product Offered
11.1.3 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis Global
11.2.1 Novartis Global Company Information
11.2.2 Novartis Global Biologic Therapeutics Product Offered
11.2.3 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Global Main Business Overview
11.2.5 Novartis Global Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Biologic Therapeutics Product Offered
11.3.3 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Biologic Therapeutics Product Offered
11.4.3 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Biologic Therapeutics Product Offered
11.5.3 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Information
11.6.2 Aurobindo Pharma Biologic Therapeutics Product Offered
11.6.3 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Aurobindo Pharma Main Business Overview
11.6.5 Aurobindo Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Biologic Therapeutics Market Size 2019-2030
2.1.2 Biologic Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biologic Therapeutics Segment by Type
2.2.1 Vaccines
2.2.2 Blood Products
2.2.3 Allergenic Extracts
2.2.4 Human Cells and Tissues
2.2.5 Gene Therapies
2.2.6 Protein
2.2.7 Cellular Therapies
2.2.8 Xenotransplantation Products
2.3 Biologic Therapeutics Market Size by Type
2.3.1 Biologic Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biologic Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Biologic Therapeutics Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Anemia
2.4.3 Cancer
2.4.4 Diabetes
2.4.5 Others
2.5 Biologic Therapeutics Market Size by Application
2.5.1 Biologic Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biologic Therapeutics Market Size Market Share by Application (2019-2024)
3 BIOLOGIC THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Biologic Therapeutics Market Size Market Share by Players
3.1.1 Global Biologic Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Biologic Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BIOLOGIC THERAPEUTICS BY REGIONS
4.1 Biologic Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Biologic Therapeutics Market Size Growth (2019-2024)
4.3 APAC Biologic Therapeutics Market Size Growth (2019-2024)
4.4 Europe Biologic Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Biologic Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Biologic Therapeutics Market Size by Country (2019-2024)
5.2 Americas Biologic Therapeutics Market Size by Type (2019-2024)
5.3 Americas Biologic Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologic Therapeutics Market Size by Region (2019-2024)
6.2 APAC Biologic Therapeutics Market Size by Type (2019-2024)
6.3 APAC Biologic Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Biologic Therapeutics by Country (2019-2024)
7.2 Europe Biologic Therapeutics Market Size by Type (2019-2024)
7.3 Europe Biologic Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Biologic Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Biologic Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Biologic Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BIOLOGIC THERAPEUTICS MARKET FORECAST
10.1 Global Biologic Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Biologic Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Biologic Therapeutics Forecast
10.1.3 APAC Biologic Therapeutics Forecast
10.1.4 Europe Biologic Therapeutics Forecast
10.1.5 Middle East & Africa Biologic Therapeutics Forecast
10.2 Americas Biologic Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Biologic Therapeutics Market Forecast
10.2.2 Canada Biologic Therapeutics Market Forecast
10.2.3 Mexico Biologic Therapeutics Market Forecast
10.2.4 Brazil Biologic Therapeutics Market Forecast
10.3 APAC Biologic Therapeutics Forecast by Region (2025-2030)
10.3.1 China Biologic Therapeutics Market Forecast
10.3.2 Japan Biologic Therapeutics Market Forecast
10.3.3 Korea Biologic Therapeutics Market Forecast
10.3.4 Southeast Asia Biologic Therapeutics Market Forecast
10.3.5 India Biologic Therapeutics Market Forecast
10.3.6 Australia Biologic Therapeutics Market Forecast
10.4 Europe Biologic Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Biologic Therapeutics Market Forecast
10.4.2 France Biologic Therapeutics Market Forecast
10.4.3 UK Biologic Therapeutics Market Forecast
10.4.4 Italy Biologic Therapeutics Market Forecast
10.4.5 Russia Biologic Therapeutics Market Forecast
10.5 Middle East & Africa Biologic Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Biologic Therapeutics Market Forecast
10.5.2 South Africa Biologic Therapeutics Market Forecast
10.5.3 Israel Biologic Therapeutics Market Forecast
10.5.4 Turkey Biologic Therapeutics Market Forecast
10.5.5 GCC Countries Biologic Therapeutics Market Forecast
10.6 Global Biologic Therapeutics Forecast by Type (2025-2030)
10.7 Global Biologic Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Biologic Therapeutics Product Offered
11.1.3 Pfizer Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis Global
11.2.1 Novartis Global Company Information
11.2.2 Novartis Global Biologic Therapeutics Product Offered
11.2.3 Novartis Global Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Global Main Business Overview
11.2.5 Novartis Global Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca Biologic Therapeutics Product Offered
11.3.3 AstraZeneca Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck Biologic Therapeutics Product Offered
11.4.3 Merck Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Biologic Therapeutics Product Offered
11.5.3 GlaxoSmithKline Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Information
11.6.2 Aurobindo Pharma Biologic Therapeutics Product Offered
11.6.3 Aurobindo Pharma Biologic Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Aurobindo Pharma Main Business Overview
11.6.5 Aurobindo Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Biologic Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Vaccines
Table 3. Major Players of Blood Products
Table 4. Major Players of Allergenic Extracts
Table 5. Major Players of Human Cells and Tissues
Table 6. Major Players of Gene Therapies
Table 7. Major Players of Protein
Table 8. Major Players of Cellular Therapies
Table 9. Major Players of Xenotransplantation Products
Table 10. Biologic Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 13. Biologic Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 16. Global Biologic Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Biologic Therapeutics Revenue Market Share by Player (2019-2024)
Table 18. Biologic Therapeutics Key Players Head office and Products Offered
Table 19. Biologic Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Biologic Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Biologic Therapeutics Market Size Market Share by Regions (2019-2024)
Table 24. Global Biologic Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Biologic Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Biologic Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Biologic Therapeutics Market Size Market Share by Country (2019-2024)
Table 28. Americas Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. Americas Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. APAC Biologic Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Table 34. APAC Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. APAC Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Europe Biologic Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Biologic Therapeutics Market Size Market Share by Country (2019-2024)
Table 40. Europe Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Europe Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Biologic Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Biologic Therapeutics
Table 51. Key Market Challenges & Risks of Biologic Therapeutics
Table 52. Key Industry Trends of Biologic Therapeutics
Table 53. Global Biologic Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Biologic Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Biologic Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Biologic Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Pfizer Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 58. Pfizer Biologic Therapeutics Product Offered
Table 59. Pfizer Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Main Business
Table 61. Pfizer Latest Developments
Table 62. Novartis Global Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 63. Novartis Global Biologic Therapeutics Product Offered
Table 64. Novartis Global Main Business
Table 65. Novartis Global Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Novartis Global Latest Developments
Table 67. AstraZeneca Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 68. AstraZeneca Biologic Therapeutics Product Offered
Table 69. AstraZeneca Main Business
Table 70. AstraZeneca Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AstraZeneca Latest Developments
Table 72. Merck Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 73. Merck Biologic Therapeutics Product Offered
Table 74. Merck Main Business
Table 75. Merck Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Merck Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 78. GlaxoSmithKline Biologic Therapeutics Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. GlaxoSmithKline Latest Developments
Table 82. Aurobindo Pharma Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 83. Aurobindo Pharma Biologic Therapeutics Product Offered
Table 84. Aurobindo Pharma Main Business
Table 85. Aurobindo Pharma Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Aurobindo Pharma Latest Developments
Table 1. Biologic Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Vaccines
Table 3. Major Players of Blood Products
Table 4. Major Players of Allergenic Extracts
Table 5. Major Players of Human Cells and Tissues
Table 6. Major Players of Gene Therapies
Table 7. Major Players of Protein
Table 8. Major Players of Cellular Therapies
Table 9. Major Players of Xenotransplantation Products
Table 10. Biologic Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 12. Global Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 13. Biologic Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 14. Global Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 15. Global Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 16. Global Biologic Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 17. Global Biologic Therapeutics Revenue Market Share by Player (2019-2024)
Table 18. Biologic Therapeutics Key Players Head office and Products Offered
Table 19. Biologic Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Biologic Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 23. Global Biologic Therapeutics Market Size Market Share by Regions (2019-2024)
Table 24. Global Biologic Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 25. Global Biologic Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 26. Americas Biologic Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 27. Americas Biologic Therapeutics Market Size Market Share by Country (2019-2024)
Table 28. Americas Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. Americas Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. Americas Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. Americas Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. APAC Biologic Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 33. APAC Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Table 34. APAC Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. APAC Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. APAC Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. APAC Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Europe Biologic Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 39. Europe Biologic Therapeutics Market Size Market Share by Country (2019-2024)
Table 40. Europe Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Europe Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Europe Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Europe Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Middle East & Africa Biologic Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Table 46. Middle East & Africa Biologic Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Table 48. Middle East & Africa Biologic Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 49. Middle East & Africa Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Table 50. Key Market Drivers & Growth Opportunities of Biologic Therapeutics
Table 51. Key Market Challenges & Risks of Biologic Therapeutics
Table 52. Key Industry Trends of Biologic Therapeutics
Table 53. Global Biologic Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 54. Global Biologic Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 55. Global Biologic Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 56. Global Biologic Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 57. Pfizer Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 58. Pfizer Biologic Therapeutics Product Offered
Table 59. Pfizer Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Pfizer Main Business
Table 61. Pfizer Latest Developments
Table 62. Novartis Global Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 63. Novartis Global Biologic Therapeutics Product Offered
Table 64. Novartis Global Main Business
Table 65. Novartis Global Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Novartis Global Latest Developments
Table 67. AstraZeneca Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 68. AstraZeneca Biologic Therapeutics Product Offered
Table 69. AstraZeneca Main Business
Table 70. AstraZeneca Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. AstraZeneca Latest Developments
Table 72. Merck Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 73. Merck Biologic Therapeutics Product Offered
Table 74. Merck Main Business
Table 75. Merck Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. Merck Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 78. GlaxoSmithKline Biologic Therapeutics Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. GlaxoSmithKline Latest Developments
Table 82. Aurobindo Pharma Details, Company Type, Biologic Therapeutics Area Served and Its Competitors
Table 83. Aurobindo Pharma Biologic Therapeutics Product Offered
Table 84. Aurobindo Pharma Main Business
Table 85. Aurobindo Pharma Biologic Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Aurobindo Pharma Latest Developments
LIST OF FIGURES
Figure 1. Biologic Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologic Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologic Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologic Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Biologic Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologic Therapeutics Market Size Market Share by Type in 2023
Figure 10. Biologic Therapeutics in Rheumatoid Arthritis
Figure 11. Global Biologic Therapeutics Market: Rheumatoid Arthritis (2019-2024) & ($ Millions)
Figure 12. Biologic Therapeutics in Anemia
Figure 13. Global Biologic Therapeutics Market: Anemia (2019-2024) & ($ Millions)
Figure 14. Biologic Therapeutics in Cancer
Figure 15. Global Biologic Therapeutics Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Biologic Therapeutics in Diabetes
Figure 17. Global Biologic Therapeutics Market: Diabetes (2019-2024) & ($ Millions)
Figure 18. Biologic Therapeutics in Others
Figure 19. Global Biologic Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Biologic Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Biologic Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Biologic Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Biologic Therapeutics Value Market Share by Country in 2023
Figure 28. United States Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Biologic Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Biologic Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Biologic Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Biologic Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Biologic Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Biologic Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Biologic Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biologic Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Biologic Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Biologic Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Biologic Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Biologic Therapeutics Market Size Market Share by Type in 2023
Figure 10. Biologic Therapeutics in Rheumatoid Arthritis
Figure 11. Global Biologic Therapeutics Market: Rheumatoid Arthritis (2019-2024) & ($ Millions)
Figure 12. Biologic Therapeutics in Anemia
Figure 13. Global Biologic Therapeutics Market: Anemia (2019-2024) & ($ Millions)
Figure 14. Biologic Therapeutics in Cancer
Figure 15. Global Biologic Therapeutics Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Biologic Therapeutics in Diabetes
Figure 17. Global Biologic Therapeutics Market: Diabetes (2019-2024) & ($ Millions)
Figure 18. Biologic Therapeutics in Others
Figure 19. Global Biologic Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Biologic Therapeutics Market Size Market Share by Application in 2023
Figure 21. Global Biologic Therapeutics Revenue Market Share by Player in 2023
Figure 22. Global Biologic Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 24. APAC Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 25. Europe Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Biologic Therapeutics Market Size 2019-2024 ($ Millions)
Figure 27. Americas Biologic Therapeutics Value Market Share by Country in 2023
Figure 28. United States Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Biologic Therapeutics Market Size Market Share by Region in 2023
Figure 33. APAC Biologic Therapeutics Market Size Market Share by Type in 2023
Figure 34. APAC Biologic Therapeutics Market Size Market Share by Application in 2023
Figure 35. China Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Biologic Therapeutics Market Size Market Share by Country in 2023
Figure 42. Europe Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Figure 43. Europe Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Figure 44. Germany Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Biologic Therapeutics Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Biologic Therapeutics Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Biologic Therapeutics Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Biologic Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. APAC Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Europe Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. United States Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Canada Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. China Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Japan Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Korea Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. India Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Australia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Germany Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. France Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. UK Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Italy Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Russia Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Spain Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Israel Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Biologic Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. Global Biologic Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Biologic Therapeutics Market Size Market Share Forecast by Application (2025-2030)
